Trial ID or NCT#

NCT00264238

Status

not recruiting iconNOT RECRUITING

Purpose

The purpose of this study is to determine whether memantine is safe and effective when used as an augmentation to standard treatment for Obsessive-Compulsive Disorder (OCD).

Official Title

An Open-Label Trial of Memantine to Augment Response in the Treatment of Obsessive-Compulsive Disorder

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

John Barry, MD
John Barry, MD
Psychiatrist
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology - Adult) and, by courtesy, of Neurology at the Stanford University Medical Center
Elias Aboujaoude, MD, MA
Psychiatrist
Clinical Professor, Psychiatry and Behavioral Sciences

Contact us to find out if this trial is right for you.

CONTACT

Nona Gamel
(650) 723-8601